- Home
- KLXE vs FGEN Comparison
KLXE vs FGEN Comparison
Compare KLXE & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLXE
- FGEN
- Stock Information
- Founded
- KLXE 2018
- FGEN 1993
- Country
- KLXE United States
- FGEN United States
- Employees
- KLXE N/A
- FGEN N/A
- Industry
- KLXE Oilfield Services/Equipment
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- KLXE Energy
- FGEN Health Care
- Exchange
- KLXE Nasdaq
- FGEN Nasdaq
- Market Cap
- KLXE 35.8M
- FGEN 33.5M
- IPO Year
- KLXE N/A
- FGEN 2014
- Fundamental
- Price
- KLXE $2.23
- FGEN $0.30
- Analyst Decision
- KLXE Hold
- FGEN Strong Buy
- Analyst Count
- KLXE 1
- FGEN 1
- Target Price
- KLXE $4.50
- FGEN $10.00
- AVG Volume (30 Days)
- KLXE 173.4K
- FGEN 594.8K
- Earning Date
- KLXE 05-08-2025
- FGEN 05-12-2025
- Dividend Yield
- KLXE N/A
- FGEN N/A
- EPS Growth
- KLXE N/A
- FGEN N/A
- EPS
- KLXE N/A
- FGEN N/A
- Revenue
- KLXE $688,600,000.00
- FGEN $6,996,000.00
- Revenue This Year
- KLXE $0.22
- FGEN $232.81
- Revenue Next Year
- KLXE $4.89
- FGEN $9.16
- P/E Ratio
- KLXE N/A
- FGEN N/A
- Revenue Growth
- KLXE N/A
- FGEN N/A
- 52 Week Low
- KLXE $1.51
- FGEN $0.18
- 52 Week High
- KLXE $7.66
- FGEN $1.74
- Technical
- Relative Strength Index (RSI)
- KLXE 49.10
- FGEN 44.76
- Support Level
- KLXE $1.80
- FGEN $0.29
- Resistance Level
- KLXE $2.42
- FGEN $0.32
- Average True Range (ATR)
- KLXE 0.24
- FGEN 0.02
- MACD
- KLXE 0.09
- FGEN 0.00
- Stochastic Oscillator
- KLXE 68.55
- FGEN 26.25
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.